Sevoflurane has no adverse effects on renal function in cirrhotic patients: A comparison with propofol

Acta Anaesthesiologica Scandinavica

Volumn 57, Issue 7, 2013, Pages 896-902

  Song, J C ^a   Zhang, M Z ^b   Wu, Q C ^c   Lu, Z J ^a   Sun, Y M ^a   Yang, L Q ^a   Yu, W F ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CISATRACURIUM; CREATININE; FENTANYL; FUROSEMIDE; HETASTARCH; LIDOCAINE; MIDAZOLAM; NITROGEN; PROPOFOL; ROPIVACAINE; SEVOFLURANE; UREA;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYSTALLOID; DRUG INTERMITTENT THERAPY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SINGLE BLIND PROCEDURE; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ADULT; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; BLOOD UREA NITROGEN; CREATININE; DIURESIS; FEMALE; FLUID THERAPY; HEPATECTOMY; HUMANS; KIDNEY; KIDNEY DISEASES; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; METHYL ETHERS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPOFOL;

EID: 84879837150     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12085     Document Type: Article

References (28)

1. Ginès P, Robert WS,. Renal failure in cirrhosis. N Engl J Med 2009; 361: 1279-1290.
2. Ginès P, Guevara M, Arroyo V, Rodés J,. Hepatorenal syndrome. Lancet 2003; 362: 1819-1827.
3. Lentschener C, Ozier Y,. What anaesthetists need to know about viral hepatitis. Acta Anaesthesiol Scand 2003; 47: 794-803.
4. Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL,. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999; 90: 42-53.
5. Gonsowski CT, Laster MJ, Eger EI 2nd, Ferrell LD, Kerschmann RL,. Toxicity of compound A in rats. Effect of increasing duration of administration. Anesthesiology 1994; 80: 566-573.
6. Eger EI 2nd, Koblin DD, Bowland T, Ionescu P, Laster MJ, Fang Z, Gong D, Sonner J, Weiskopf RB,. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997; 84: 160-168.
7. Ebert TJ, Frink EJ Jr, Kharasch ED,. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology 1998; 88: 601-610.
8. Conzen PF, Kharasch ED, Czerner SF, Artru AA, Reichle FM, Michalowski P, Rooke GA, Weiss BM, Ebert TJ,. Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficiency. Anesthesiology 2002; 97: 578-584.
9. Edward J, Frink JR,. Toxicologic potential of desflurane and sevoflurane. Acta Anaesthesiol Scand 1995; 39: 120-122.
10. Song JC, Sun YM, Yang LQ, Zhang MZ, Lu ZJ, Yu WF,. A comparison of liver function after hepatectomy with inflow occlusion between sevoflurane and propofol anesthesia. Anesth Analg 2010; 111: 1036-1041.
11. Mazze RI, Callan CM, Galvez ST, Herrera LD, Mayer DB,. The effects of sevoflurane on serum creatinine and blood urea nitrogen concentrations: a retrospective, twenty-two-center, comparative evaluation of renal function in adult surgical patients. Anesth Analg 2000; 90: 683-688.
12. Lerman J,. Study design in clinical research: sample size estimation and power analysis. Can J Anaesth 1996; 43: 184-191.
13. Pain JA, Cahill CJ, Bailey ME,. Perioperative complications in obstructive jaundice: therapeutic considerations. Br J Surg 1985; 72: 942-945.
14. Gonsowski CT, Laster MJ, Eger EI 2nd, Ferrell LD, Kerschmann RL,. Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology 1994; 80: 556-565.
15. Hara T, Fukusaki M, Nakamura T, Sumikawa K,. Renal function in patients during and after hypotensive anesthesia with sevoflurane. J Clin Anesth 1998; 10: 539-545.
16. Goldberg ME, Cantillo J, Gratz I, Deal E, Vekeman D, McDougall R, Afshar M, Zafeiridis A, Larijani G,. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers. Anesth Analg 1999; 88: 437-445.
17. Ebert TJ, Arain SR,. Renal responses to low-flow desflurane, sevoflurane, and propofol in patients. Anesthesiology 2000; 93: 1401-1406.
18. SarinKapoor H, Kaur R, Kaur H,. Anaesthesia for renal transplant surgery. Acta Anaesthesiol Scand 2007; 51: 1354-1367.
19. Röhm KD, Mengistu A, Boldt J, Mayer J, Beck G, Piper SN,. Renal integrity in sevoflurane sedation in the intensive care unit with the anesthetic-conserving device: a comparison with intravenous propofol sedation. Anesth Analg 2009; 108: 1848-1854.
20. Farrell GC, Zaluzny L,. Hepatic heme metabolism and cytochrome P450 in cirrhotic rat liver. Gastroenterology 1985; 89: 172-179.
21. Cook TL, Beppu WJ, Hitt BA, Kosek JC, Mazze RI,. Renal effects and metabolism of sevoflurane in Fisher 3444 rats: an in-vivo and in-vitro comparison with methoxyflurane. Anesthesiology 1975; 43: 70-76.
22. Annecke T, Chappell D, Chen C, Jacob M, Welsch U, Sommerhoff CP, Rehm M, Conzen PF, Becker BF,. Sevoflurane preserves the endothelial glycocalyx against ischaemia-reperfusion injury. Br J Anaesth 2010; 104: 414-421.
23. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, Jochum W, Spahn DR, Graf R, Clavien P-A,. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008; 248: 909-918.
24. Wong GTC, Irwin MG,. Contrast-induced nephropathy. Br J Anaesth 2007; 99: 474-483.
25. Craig RG, Hunter JM,. Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaesth 2008; 101: 296-310.
26. Mehta RL, Clark WC, Schetz M,. Techniques for assessing and achieving fluid balance in acute renal failure. Curr Opin Crit Care 2002; 8: 535-543.
27. Sear JW,. Kidney dysfunction in the postoperative period. Br J Anaesth 2005; 95: 20-32.
28. Bundgaard-Nielsen M, Secher NH, Kehlet H,. 'Liberal' vs. 'restrictive' perioperative fluid therapy-a critical assessment of the evidence. Acta Anaesthesiol Scand 2009; 53: 843-851.